Urinary Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Urinary Catheters Pipeline Market Report Overview

A urinary catheter is a tube system to drain and collect urine from the bladder. These are used to manage urinary incontinence and urinary retention in both men and women.

The Urinary Catheters pipeline market research report provides extensive coverage of the Urinary Catheters under development. It reviews details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. Additionally, it reviews major players involved in the pipeline product development. The report also provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Urinary Catheters pipeline products.

Key Territories ·        The United States

·        Europe

·        Canada

·        Taiwan

·        United Kingdom

·        China

·        Singapore

Key Categories ·        Foley Catheters

·        External Urinary Catheters

·        Suprapubic Catheters

Key Regulatory Paths ·        510(k)

·        CE

·        BOPA

·        MDL

·        UKCA

·        NMPA

Leading Companies ·        All India Institute of Medical Sciences

·        Aurie

·        Biocrede Inc

·        BioModics ApS

·        Brighton Development LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Urinary Catheters Pipeline Market Segmentation by Categories

The key categories in the Urinary Catheters pipeline market are Foley Catheters, External Urinary Catheters, and Suprapubic Catheters. Foley Catheters leads the Urinary Catheters pipeline market as of May 2024.

Urinary Catheters Pipeline Market Analysis by Categories, 2024 (%)

Urinary Catheters Pipeline Market Analysis by Categories, 2024 (%)

Buy the Full Report for More Territory Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Urinary Catheters Pipeline Market Segmentation by Territories

The key territories with the Urinary Catheters pipeline market are the United States, Europe, Canada, Taiwan, China, Singapore, and the United Kingdom. As of May 2024, the US accounts for the highest number of Urinary Catheters products.

Urinary Catheters Pipeline Market Analysis by Territories, 2024 (%)

Urinary Catheters Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Urinary Catheters Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the Urinary Catheters pipeline market are 510(k), CE, BOPA, MDL, UKCA, and NMPA. As of May 2024, 510(k) is the most followed pathway for pipeline products in the Urinary Catheters pipeline market.

Urinary Catheters Market Analysis by Regulatory Paths, 2024 (%)

Urinary Catheters Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Urinary Catheters Pipeline Market – Competitive Landscape

A few of the key companies associated with the Urinary Catheters pipeline market are All India Institute of Medical Sciences, Aurie, Biocrede Inc, BioModics ApS, and Brighton Development LLC among others.

All India Institute of Medical Sciences (AIIMS): All India Institute of Medical Sciences (AIIMS) is a medical institution that provides medical education, biomedical research, and healthcare services. It offers research services, teaching services, medical services, nursing services, and laboratory services among others. The institution also provides DM (Doctorate of Medicine) and MCh (Master of Chirurgiae) super specialty courses in the areas of cardiology, gastroenterology, endocrinology, neurology, nephrology, oncology, cardiothoracic and neurosurgery. AIIMS conducts research in the fields of neurosciences, genetics, and computer simulation of hormone-receptor interaction. It applies DNA recombinant technology, immunology, and electron microscopy to study diseases such as leprosy, malaria, tuberculosis, diabetes, diarrhea, hepatitis, fluorosis, and iodine deficiency. AIIMS is headquartered in New Delhi, India.

Urinary Catheters Pipeline Market Analysis by Companies, 2024

Urinary Catheters Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Urinary Catheters Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Urinary Catheters Pipeline Market Territories Outlook (As of May 2024)

  • The United States
  • Europe
  • Canada
  • Taiwan
  • The United Kingdom
  • China
  • Singapore

Urinary Catheters Pipeline Market Regulatory Paths Outlook (As of May 2024)

  • 510(k)
  • CE
  • BOPA
  • MDL
  • UKCA
  • NMPA

Urinary Catheters Pipeline Market Category Outlook (As of May 2024)

  • Foley Catheters
  • External Urinary Catheters
  • Suprapubic Catheters

Scope

This report provides:

  • Extensive coverage of the Urinary Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of Urinary Catheters and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Urinary Catheters under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

All India Institute of Medical Sciences
Aurie
Biocrede Inc
BioModics ApS
Brighton Development LLC
Camstent Ltd
Ceragenix Pharmaceuticals, Inc. (Inactive)
Chain Antimicrobials Ltd
Coloplast A/S
Control Flo Medical LLC
Dongguan TT Medical Inc
Enox Biopharma Inc (Inactive)
Flat Medical Inc
Flume Catheter Co Ltd
FocusStart LLC
Ingenion Medical Ltd
InterVaal Pte Ltd
Laborie Medical Technologies Inc
Leading Age Supplies LLC
Montana State University
N8 Medical LLC
Olympus Endo Technology America Inc
OTU Medical Inc
Provenmed
Pyriscence LLC
Riocath Global AS
Sharklet Technologies Inc
The University of Nottingham
Tractivus SL
University of Amsterdam
University of California San Diego
University of South Florida
University of Texas Health Science Center at San Antonio
University of Utah
UroDeflect
UroDev Medical
Xennovate Medical LLC

Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 10

2.1 Urinary Catheters Overview 10

3 Products under Development 11

3.1 Urinary Catheters – Pipeline Products by Stage of Development 11

3.2 Urinary Catheters – Pipeline Products by Segment 12

3.3 Urinary Catheters – Pipeline Products by Territory 13

3.4 Urinary Catheters – Pipeline Products by Regulatory Path 14

3.5 Urinary Catheters – Pipeline Products by Estimated Approval Date 15

3.6 Urinary Catheters – Ongoing Clinical Trials 16

4 Urinary Catheters – Pipeline Products under Development by Companies 17

4.1 Urinary Catheters Companies – Pipeline Products by Stage of Development 17

4.2 Urinary Catheters – Pipeline Products by Stage of Development 19

5 Urinary Catheters Companies and Product Overview 21

5.1 All India Institute of Medical Sciences Company Overview 21

5.1.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Aurie Company Overview 22

5.2.1 Aurie Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Biocrede Inc Company Overview 23

5.3.1 Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 BioModics ApS Company Overview 24

5.4.1 BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Brighton Development LLC Company Overview 25

5.5.1 Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Camstent Ltd Company Overview 26

5.6.1 Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 29

5.7.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Chain Antimicrobials Ltd Company Overview 30

5.8.1 Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Coloplast A/S Company Overview 31

5.9.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Control Flo Medical LLC Company Overview 33

5.10.1 Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 Dongguan TT Medical Inc Company Overview 34

5.11.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 Enox Biopharma Inc (Inactive) Company Overview 35

5.12.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 Flat Medical Inc Company Overview 36

5.13.1 Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 Flume Catheter Co Ltd Company Overview 38

5.14.1 Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 FocusStart LLC Company Overview 41

5.15.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 41

5.16 Ingenion Medical Ltd Company Overview 42

5.16.1 Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 InterVaal Pte Ltd Company Overview 43

5.17.1 InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 Laborie Medical Technologies Inc Company Overview 44

5.18.1 Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.19 Leading Age Supplies LLC Company Overview 45

5.19.1 Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 45

5.20 Montana State University Company Overview 46

5.20.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 46

5.21 N8 Medical LLC Company Overview 47

5.21.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 47

5.22 Olympus Endo Technology America Inc Company Overview 48

5.22.1 Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.23 OTU Medical Inc Company Overview 49

5.23.1 OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.24 Provenmed Company Overview 51

5.24.1 Provenmed Pipeline Products & Ongoing Clinical Trials Overview 51

5.25 Pyriscence LLC Company Overview 52

5.25.1 Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 52

5.26 Riocath Global AS Company Overview 53

5.26.1 Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 53

5.27 Sharklet Technologies Inc Company Overview 58

5.27.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.28 The University of Nottingham Company Overview 59

5.28.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 59

5.29 Tractivus SL Company Overview 60

5.29.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 60

5.30 University of Amsterdam Company Overview 61

5.30.1 University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 61

5.31 University of California San Diego Company Overview 62

5.31.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 62

5.32 University of South Florida Company Overview 63

5.32.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 63

5.33 University of Texas Health Science Center at San Antonio Company Overview 64

5.33.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 64

5.34 University of Utah Company Overview 65

5.34.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 65

5.35 UroDeflect Company Overview 66

5.35.1 UroDeflect Pipeline Products & Ongoing Clinical Trials Overview 66

5.36 UroDev Medical Company Overview 67

5.36.1 UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 67

5.37 Xennovate Medical LLC Company Overview 68

5.37.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 68

6 Urinary Catheters- Recent Developments 69

6.1 Apr 30, 2024: Coloplast Receives 510(K) Clearance For Folysil Silicone Catheter 69

6.2 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 69

6.3 Apr 17, 2024: SeaStar Medical Reports 2023 Financial Results and Provides a Business Update 69

6.4 Apr 11, 2024: Bactiguard Holding Announces Annual and Sustainability Report 2023 71

6.5 Apr 02, 2024: Medline Expands Catheter Portfolio with QiVi MEC Male External Urine Management Device 71

6.6 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 72

6.7 Feb 28, 2024: Covalon to Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024 72

6.8 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company 72

6.9 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering 73

6.10 Feb 22, 2024: Sanofi’s Board of Directors Proposes the Appointment of Clotilde Delbos, Anne-Francoise Nesmes and John Sundy as Independent Directors 73

6.11 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent 74

6.12 Feb 09, 2024: Coloplast Announces Interim Financial Report, Q1 2023/24 74

6.13 Feb 08, 2024: ConvaTec Group Receives 510(K) Clearance For GentleCath Air for Women 75

6.14 Feb 08, 2024: Silq Technologies Received Additional 510(K) Clearance For 2-Way 100% Silicone ClearTract Catheter 75

6.15 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information 75

6.16 Feb 07, 2024: Bactiguard Holding Appoints Christine Lind as New CEO 75

6.17 Feb 01, 2024: Sanofi Announces Quarterly Earnings Report and Stock Performance Analysis 76

6.18 Feb 01, 2024: Francois-Xavier Roger Appointed Chief Financial Officer, Member of Sanofi Executive Committee 76

6.19 Feb 01, 2024: Bactiguard Holding Announces Invitation to Presentation of Year-end Report for 2023 77

6.20 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 77

6.21 Jan 26, 2024: Covalon Announces Management Changes 79

6.22 Jan 09, 2024: Brian Foard Appointed Head of Specialty Care Global Business Unit, Member of Sanofi Executive Committee 79

6.23 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results 80

6.24 Jan 04, 2024: Covalon Technologies Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO 80

6.25 Nov 14, 2023: SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update 81

6.26 Nov 13, 2023: INVO Reports Record Third Quarter 2023 Financial Results 84

6.27 Nov 09, 2023: Coloplast Reports Annual Report 2022/23 85

6.28 Nov 07, 2023: ProstaLund Announces Interim Report 86

6.29 Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook 87

6.30 Nov 02, 2023: Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member 87

6.31 Oct 27, 2023: Bactiguard Holding Announces Interim Report Q3 2023 87

6.32 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 89

6.33 Oct 10, 2023: HR Pharmaceuticals, Significantly Expands the Trucath Portfolio With Two New Offerings of Ready-To-Use Intermittent Catheters Delivering Optimal Protection, Comfort, and Convenience 91

6.34 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 92

6.35 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 92

6.36 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 93

6.37 Sep 08, 2023: Coloplast Receives 510(k) Clearance for Luja 93

6.38 Aug 31, 2023: Sanofi Appoints a Venture Investor to R&D Head as Executive Team Expands 93

6.39 Aug 29, 2023: Coloplast Launches Offering to Raise Around Dkk 9 Billion Through Issue of New B Shares in a Directed Issue and Private Placement 93

6.40 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 95

6.41 Aug 18, 2023: Coloplast Receives 510(k) Clearance for Self-Cath Closed System 95

6.42 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 95

6.43 Aug 10, 2023: Teleflex Medical Receives 510(k) Clearance for Rusch SoftSimplastic Foley Catheter 95

6.44 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 95

6.45 Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook 96

6.46 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 99

6.47 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 100

6.48 Jul 12, 2023: Flume Catheter Receives Additional 510(k) Clearance for Flume Catheter 100

6.49 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO 100

6.50 Jun 26, 2023: Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida 101

6.51 Jun 13, 2023: Well Lead Medical Receives Additional 510(k) Clearance for PVC Hydrophilic Urethral Catheter 101

7 Appendix 103

7.1 Methodology 103

7.2 About GlobalData 106

7.3 Contact Us 106

7.4 Disclaimer 106

Table

Urinary Catheters – Pipeline Products by Stage of Development 11

Urinary Catheters – Pipeline Products by Segment 12

Urinary Catheters – Pipeline Products by Territory 13

Urinary Catheters – Pipeline Products by Regulatory Path 14

Urinary Catheters – Pipeline Products by Estimated Approval Date 15

Urinary Catheters – Ongoing Clinical Trials 16

Urinary Catheters Companies – Pipeline Products by Stage of Development 17

Urinary Catheters – Pipeline Products by Stage of Development 19

All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 21

Super Hydrophobic Catheter – Product Status 21

Super Hydrophobic Catheter – Product Description 21

Aurie Pipeline Products & Ongoing Clinical Trials Overview 22

Reusable Intermittent Catheter System – Product Status 22

Reusable Intermittent Catheter System – Product Description 22

Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Urinary Catheter – Product Status 23

Urinary Catheter – Product Description 23

BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 24

Indwelling Urinary Catheter – Product Status 24

Indwelling Urinary Catheter – Product Description 24

Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 25

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Status 25

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Description 25

Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

Camstent Coated Foley Catheter – Product Status 26

Camstent Coated Foley Catheter – Product Description 26

Camstent Ltd – Ongoing Clinical Trials Overview 27

Camstent Coated Foley Catheter – A Prospective Multicentre Randomized Study to Assess the Impact of a Catheter Coating on Clinical Bacteriuria 28

Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

Cerashield Coated Silicone Urinary Catheter – Product Status 29

Cerashield Coated Silicone Urinary Catheter – Product Description 29

Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Peptide-Coated Catheter – Product Status 30

Peptide-Coated Catheter – Product Description 30

Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 31

Luja – Product Status 31

Luja – Product Description 32

Single-Use Compact Female Intermittent Catheter – Product Status 32

Single-Use Compact Female Intermittent Catheter – Product Description 32

Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 33

ResQ Urological Catheter System – Product Status 33

ResQ Urological Catheter System – Product Description 33

Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 34

Drug-coated Catheter – Product Status 34

Drug-coated Catheter – Product Description 34

Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

Self-Sterilizing Urinary Catheter – Product Status 35

Self-Sterilizing Urinary Catheter – Product Description 35

Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 36

UroAid – F – Product Status 36

UroAid – F – Product Description 36

UroAid – IV – Product Status 37

UroAid – IV – Product Description 37

Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Flume Catheter – Product Status 38

Flume Catheter – Product Description 38

Flume Catheter Co Ltd – Ongoing Clinical Trials Overview 39

Flume Catheter – FLUME Catheter Comfort Study 40

FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 41

Anti-biofilm Urological Catheter – Product Status 41

Anti-biofilm Urological Catheter – Product Description 41

Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 42

FemActive Catheter – Product Status 42

FemActive Catheter – Product Description 42

InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

InterVaal Catheter – Product Status 43

InterVaal Catheter – Product Description 43

Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 44

T-DOC 5Fr Air-Charged Catheter – Product Status 44

T-DOC 5Fr Air-Charged Catheter – Product Description 44

Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 45

Urinary Catheter – Product Status 45

Urinary Catheter – Product Description 45

Montana State University Pipeline Products & Ongoing Clinical Trials Overview 46

Safety Adaptor For Foley Catheter – Product Status 46

Safety Adaptor For Foley Catheter – Product Description 46

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 47

CeraShield Urinary Catheter – Product Status 47

CeraShield Urinary Catheter – Product Description 47

Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 48

Uro-Ease – Product Status 48

Uro-Ease – Product Description 48

OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 49

NextGen Purewick – Product Status 49

NextGen Purewick – Product Description 49

Portable Purewick – Product Status 50

Portable Purewick – Product Description 50

Purewick No Touch – Product Status 50

Purewick No Touch – Product Description 50

Provenmed Pipeline Products & Ongoing Clinical Trials Overview 51

ActivGo Kit – Product Status 51

ActivGo Kit – Product Description 51

Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 52

Anti-Microbial Catheter – Product Status 52

Anti-Microbial Catheter – Product Description 52

Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 53

Epicystostomy Catheter – Product Status 53

Epicystostomy Catheter – Product Description 53

Female Urinary Catheter Permanent – Product Status 54

Female Urinary Catheter Permanent – Product Description 54

Female Urinary Catheter Simple – Product Status 54

Female Urinary Catheter Simple – Product Description 55

Female Urinary Catheter With Insertion Tool – Product Status 55

Female Urinary Catheter With Insertion Tool – Product Description 55

Male Urinary Catheter Permanent – Product Status 56

Male Urinary Catheter Permanent – Product Description 56

Male Urinary Catheter With Insertion Tool – Product Status 56

Male Urinary Catheter With Insertion Tool – Product Description 57

Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Foley Urinary Catheter – Product Status 58

Foley Urinary Catheter – Product Description 58

The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 59

Antimicrobial Catheter – Product Status 59

Antimicrobial Catheter – Product Description 59

Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 60

UroPHOB urinary catheter – Product Status 60

UroPHOB urinary catheter – Product Description 60

University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 61

Percutaneous Nephrostomy Catheter – Product Status 61

Percutaneous Nephrostomy Catheter – Product Description 61

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 62

Urethral Catheter – Product Status 62

Urethral Catheter – Product Description 62

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 63

Urethral Catheter Guidance System – Product Status 63

Urethral Catheter Guidance System – Product Description 63

University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 64

Time Sensitive Foley Catheter Alarm – Product Status 64

Time Sensitive Foley Catheter Alarm – Product Description 64

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 65

AdvanceCath Catheter – Product Status 65

AdvanceCath Catheter – Product Description 65

UroDeflect Pipeline Products & Ongoing Clinical Trials Overview 66

Urinary System Catheter – Product Status 66

Urinary System Catheter – Product Description 66

UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 67

Connected Catheter System – Product Status 67

Connected Catheter System – Product Description 67

Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 68

Vortex ZDS Urinary Retention Catheter – Product Status 68

Vortex ZDS Urinary Retention Catheter – Product Description 68

Glossary 105

Figures

Urinary Catheters – Pipeline Products by Stage of Development 11

Urinary Catheters – Pipeline Products by Segment 12

Urinary Catheters – Pipeline Products by Territory 13

Urinary Catheters – Pipeline Products by Regulatory Path 14

Urinary Catheters – Pipeline Products by Estimated Approval Date 15

Urinary Catheters – Ongoing Clinical Trials 16

Frequently asked questions

Urinary Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Urinary Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Urinary Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Urinary Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.